ITBO910114A0 - Formulazioni farmaceutiche a rilascio controllato per uso orale ga- stroresistenti contenenti acidi biliari e loro sali - Google Patents

Formulazioni farmaceutiche a rilascio controllato per uso orale ga- stroresistenti contenenti acidi biliari e loro sali

Info

Publication number
ITBO910114A0
ITBO910114A0 IT91BO114A ITBO910114A ITBO910114A0 IT BO910114 A0 ITBO910114 A0 IT BO910114A0 IT 91BO114 A IT91BO114 A IT 91BO114A IT BO910114 A ITBO910114 A IT BO910114A IT BO910114 A0 ITBO910114 A0 IT BO910114A0
Authority
IT
Italy
Prior art keywords
gastro
salts
controlled release
pharmaceutical formulations
oral use
Prior art date
Application number
IT91BO114A
Other languages
English (en)
Inventor
Egidio Marchi
Gianfranco Tamagnone
Leone Gabriele Rotini
Original Assignee
Alfa Wassermann
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Wassermann filed Critical Alfa Wassermann
Publication of ITBO910114A0 publication Critical patent/ITBO910114A0/it
Priority to ITBO910114A priority Critical patent/IT1245891B/it
Priority to US07/861,462 priority patent/US5300300A/en
Priority to EP92105717A priority patent/EP0508312B1/en
Priority to ES92105717T priority patent/ES2091970T3/es
Priority to TW081102518A priority patent/TW215899B/zh
Priority to DE69213800T priority patent/DE69213800T2/de
Priority to CA002065652A priority patent/CA2065652C/en
Priority to JP4091131A priority patent/JP2509046B2/ja
Priority to KR1019920006053A priority patent/KR970005177B1/ko
Publication of ITBO910114A1 publication Critical patent/ITBO910114A1/it
Application granted granted Critical
Publication of IT1245891B publication Critical patent/IT1245891B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ITBO910114A 1991-04-12 1991-04-12 Formulazioni farmaceutiche a rilascio controllato per uso orale gastroresistenti contenenti acidi biliari e loro sali. IT1245891B (it)

Priority Applications (9)

Application Number Priority Date Filing Date Title
ITBO910114A IT1245891B (it) 1991-04-12 1991-04-12 Formulazioni farmaceutiche a rilascio controllato per uso orale gastroresistenti contenenti acidi biliari e loro sali.
US07/861,462 US5300300A (en) 1991-04-12 1992-04-01 Controlled release gastroresistant pharmaceutical formulations for oral administration containing bile acids and their salts
TW081102518A TW215899B (it) 1991-04-12 1992-04-02
ES92105717T ES2091970T3 (es) 1991-04-12 1992-04-02 Formulaciones farmaceuticas gastrorresistentes de liberacion controlada para administracion oral que contienen acidos biliares y sus sales.
EP92105717A EP0508312B1 (en) 1991-04-12 1992-04-02 Controlled release gastroresistant pharmaceutical formulations for oral administration containing bile acids and their salts
DE69213800T DE69213800T2 (de) 1991-04-12 1992-04-02 Oral anzuwendende magensaftstabile Arzneimittel mit gesteuerter Wirkstoffabgabe enthaltend Gallensäuren und deren Salze
CA002065652A CA2065652C (en) 1991-04-12 1992-04-10 Controlled release gastroresistant pharmaceutical formulations for oral administration containing bile acids and their salts
JP4091131A JP2509046B2 (ja) 1991-04-12 1992-04-10 胆汁酸およびその塩を含有する経口投与用の放出制御型胃液耐性製剤
KR1019920006053A KR970005177B1 (ko) 1991-04-12 1992-04-11 담즙산과 그 염을 함유하는 경구용 방출제어 위내성 위약 의약 포뮬레이션

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITBO910114A IT1245891B (it) 1991-04-12 1991-04-12 Formulazioni farmaceutiche a rilascio controllato per uso orale gastroresistenti contenenti acidi biliari e loro sali.

Publications (3)

Publication Number Publication Date
ITBO910114A0 true ITBO910114A0 (it) 1991-04-12
ITBO910114A1 ITBO910114A1 (it) 1992-10-12
IT1245891B IT1245891B (it) 1994-10-25

Family

ID=11337392

Family Applications (1)

Application Number Title Priority Date Filing Date
ITBO910114A IT1245891B (it) 1991-04-12 1991-04-12 Formulazioni farmaceutiche a rilascio controllato per uso orale gastroresistenti contenenti acidi biliari e loro sali.

Country Status (9)

Country Link
US (1) US5300300A (it)
EP (1) EP0508312B1 (it)
JP (1) JP2509046B2 (it)
KR (1) KR970005177B1 (it)
CA (1) CA2065652C (it)
DE (1) DE69213800T2 (it)
ES (1) ES2091970T3 (it)
IT (1) IT1245891B (it)
TW (1) TW215899B (it)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9212511D0 (en) * 1992-06-12 1992-07-22 Cortecs Ltd Pharmaceutical compositions
IT1255968B (it) * 1992-11-27 1995-11-17 Composizioni farmaceutiche contenenti acido ursodesossicolico
NZ260408A (en) * 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
US5891471A (en) * 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US5843480A (en) * 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
DE29717252U1 (de) * 1997-09-26 1998-02-19 Dr. Falk Pharma GmbH, 79108 Freiburg Arzneimittelkit aus einem Budesonid-haltigen und einem Ursodesoxycholsäure-haltigen Arzneimittel zur Behandlung von cholestatischen Lebererkrankungen
US20050158408A1 (en) * 1998-07-24 2005-07-21 Yoo Seo H. Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof
US7303768B2 (en) * 1998-07-24 2007-12-04 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
RU2224523C2 (ru) 1998-07-24 2004-02-27 Сео Хонг Ю Водный раствор, содержащий желчную кислоту, и способ его получения
US7772220B2 (en) * 2004-10-15 2010-08-10 Seo Hong Yoo Methods and compositions for reducing toxicity of a pharmaceutical compound
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
WO2001056547A2 (en) * 2000-02-04 2001-08-09 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
US6821931B2 (en) * 2002-03-05 2004-11-23 Alpine Mud Products Corporation Water-based drilling fluid additive containing talc and carrier
US20040241252A1 (en) * 2003-05-29 2004-12-02 Abney Christopher Charles Pharmaceutical compositions for oral administration comprising lithium carbonate, processes of making the same, and methods of administering the same
US7145125B2 (en) * 2003-06-23 2006-12-05 Advanced Optical Technologies, Llc Integrating chamber cone light using LED sources
EP1696910A4 (en) * 2003-09-26 2009-12-09 Smithkline Beecham Corp COMPOSITIONS AND METHOD FOR THE TREATMENT OF FIBROSIS
US20050181047A1 (en) * 2004-02-18 2005-08-18 Jaime Romero Compositions and methods for timed release of water-soluble nutritional supplements
US7491263B2 (en) * 2004-04-05 2009-02-17 Technology Innovation, Llc Storage assembly
JP2008511651A (ja) * 2004-08-30 2008-04-17 セオ ホン ユー 局所虚血モデルでの可溶化ｕｄｃａの神経保護効果
BRPI0518191A (pt) * 2004-10-15 2008-11-04 Seo Hong Yoo métodos e composições para reduzir a toxicidade de um composto farmacêutico
CA2585471A1 (en) * 2004-11-01 2006-05-11 Seo Hong Yoo Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis
US20060275364A1 (en) * 2005-05-26 2006-12-07 Ahmed Salah U Flexible Solid Dosage Forms and Methods of Making and Using the Same
SI2124884T1 (sl) * 2006-12-22 2019-09-30 Ironwood Pharmaceuticals, Inc. Pripravki, ki obsegajo sekvestrante žolčnih kislin, za zdravljenje motenj požiralnika
KR101636958B1 (ko) * 2009-09-11 2016-07-06 주식회사 대웅제약 우루소데옥시콜린산-합성하이드로탈사이트-유드라짓 혼성체, 이를 함유하는 약학 조성물 및 그 제조방법
EP2765998A1 (en) 2011-10-11 2014-08-20 Ranbaxy Laboratories Limited A gastroretentive dosage system and process of preparation thereof
US20170119680A1 (en) 2015-10-30 2017-05-04 R.P. Scherer Technologies, Llc Extended release film-coated capsules

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2340060A1 (de) * 1973-08-08 1975-02-20 Scherer Gmbh R P Magensaftresistente gelatinekapseln und verfahren zu deren herstellung
IT1101649B (it) * 1978-12-15 1985-10-07 Lehner Ag Composizione farmaceutica ad azione prolungata contenente acidi biliari
GB2189699A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
IT1212141B (it) 1987-06-03 1989-11-08 So Ri Far S R L Composizioni farmaceutiche per la prevenzione e terapia della calcolosi delle vie biliari e della dispepsia biliare.

Also Published As

Publication number Publication date
CA2065652A1 (en) 1992-10-13
ES2091970T3 (es) 1996-11-16
KR970005177B1 (ko) 1997-04-14
TW215899B (it) 1993-11-11
IT1245891B (it) 1994-10-25
US5300300A (en) 1994-04-05
DE69213800T2 (de) 1997-02-20
JPH0597677A (ja) 1993-04-20
KR920019360A (ko) 1992-11-19
EP0508312B1 (en) 1996-09-18
ITBO910114A1 (it) 1992-10-12
DE69213800D1 (de) 1996-10-24
CA2065652C (en) 1999-01-12
JP2509046B2 (ja) 1996-06-19
EP0508312A1 (en) 1992-10-14

Similar Documents

Publication Publication Date Title
ITBO910114A0 (it) Formulazioni farmaceutiche a rilascio controllato per uso orale ga- stroresistenti contenenti acidi biliari e loro sali
ITBO910112A0 (it) Formulazioni farmaceutiche per uso orale gastroresistenti contenenti sali di acidi biliari
ITBO910113A0 (it) Formulazioni farmaceutiche per uso orale castroresistenti contenenti acidi biliari
AT400295B (de) Orale feste pharmazeutische dosierungsform mit programmierter wirkstofffreisetzung und verfahren zu ihrer herstellung
ITMI931631A0 (it) Composizioni farmaceutiche a rilascio controllato a base di uno o piu'sali farmaceuticamente accettabili dell'acido gamma-idrossi-butirrico.
ITBO910024A0 (it) Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale
ITMI931324A1 (it) Composizioni farmaceutiche contenenti sali dell'acido s(+)-2-(4-isobutilfenil) propionico con amminoacidi basici
IT8820145A0 (it) Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione.
DE69621885D1 (de) Neue galenische orale pharmazeutische formulierung
DE69231965D1 (de) Pharmazeutische formulierungen
DE3650657D1 (de) Pharmazeutische Formulierung mit gesteuerter Freigabe
ATE252379T1 (de) Orale pharmazeutische dosierungsform beruhend auf stossweiser freisetzung
DK0814797T3 (da) Parenterale farmaceutiske præparater indeholdende alkylammoniumsalte fra 2-arylpropionsyrer
NO922226D0 (no) 7-isoindolinyl-kinolon- og naftyridonkarboksylsyre-derivater
ITBO920183A1 (it) Composizione farmaceutica a base di acidi biliari in microgranuli a rilascio controllato
ITMI911804A0 (it) Sali solubili dell'ibuprofen e naproxen c0n n-(2-idrossietil) pirrolidina e composizioni farmaceutiche che li contengono.
EE03744B1 (et) Valproehapet sisaldavad farmatseutilised mikrokerakesed oraalseks manustamiseks
NO921840D0 (no) Substituerte karboksylsyrederivater
ITMI921445A1 (it) Sali del glutatione etilestere
ITFI910003A0 (it) Procedimento per la preparazione di acidi difosfonici e loro sali
ZA873373B (en) Controlled release ketoprofen pharmaceutical formulation
DK670589D0 (da) Carboxylsyrederivater
IT9020943A0 (it) Composizione farmaceutica per uso orale a rilascio modificato di antiinfiammatori non steroidei
DE69624992T2 (de) Pharmazeutische Zusammensetzungen zum topischen Gebrauch enthaltend Ketoprofen
AU1761192A (en) 3-amino-5-arylpyrazole-4-acetic acid derivatives exhibiting therapeutic effects

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970423